The venture capital landscape is undergoing a profound transformation, signaling a clear message to late-stage startups: go big, or be prepared to finance your own growth. This increasingly stark mindset among investors is leading to the swift disappearance of smaller late-stage funding rounds, a trend that is reshaping the entire startup ecosystem and challenging traditional notions of venture-backed growth.

While the overall volume of late-stage investment has surged to unprecedented levels in recent years, a deeper dive into the data reveals a critical divergence. The lion’s share of this capital is being channeled into a select few "mega-rounds," leaving smaller deals, particularly those under $30 million, increasingly starved for capital. This isn’t a new phenomenon, but rather an accelerating trend that has now reached a critical juncture. According to Crunchbase data, funding allocated to late-stage rounds of $30 million and below has seen a consistent, six-year decline, a persistent weakening that has now pushed these rounds to historic lows.

The figures for 2025 painted a grim picture for these smaller late-stage endeavors. U.S. investment in Series C and beyond rounds totaling $30 million or less amounted to a mere $1.36 billion across just 69 deals. To put this into perspective, this sum represented less than 2% of all late-stage investments that year, a stark indication of their diminishing relevance. However, the early weeks of 2026 suggest an even more dramatic acceleration of this decline. Preliminary data indicates that these smaller rounds have accounted for approximately 0.2% of all late-stage funding so far this year – a record low that underscores the rapidity with which this segment of the market is contracting. If this trend holds, 2026 could see these rounds virtually vanish from the funding radar, further solidifying the dominance of outsized deals.

Wandering Down Later-Stage Memory Lane: A Decisive Shift

For those tracking the current climate of venture capital, where "giant financings" and multi-billion-dollar rounds are becoming commonplace, the small share of funding going to sub-$30 million rounds might not immediately strike as surprising. Indeed, these are often referred to as the "glory days of generative AI," a sector where a $40 billion valuation or even a $40 billion funding round is no longer a fantastical notion but an actual, tangible occurrence. The sheer scale of capital being deployed into a handful of AI titans naturally skews overall investment figures, making the absence of smaller deals seem less impactful on the surface.

Yet, it wasn’t so long ago that smaller late-stage rounds were not just a significant, but a foundational, part of the startup funding pipeline. Cast your mind back to 2016, a mere decade ago, and the landscape was remarkably different. In that year, more than half of all later-stage rounds were below the $30 million threshold. These rounds collectively constituted more than a sixth of all investment at that stage, serving as crucial lifelines for a diverse array of companies poised for growth, but perhaps not yet on the path to unicorn status. They represented a vital bridge for businesses demonstrating solid traction and market fit, allowing them to scale, expand, and mature without necessarily needing to raise hundreds of millions.

Fast forward to last year, 2025, and the contrast is stark. Sub-$30 million late-stage rounds had dwindled to just 16% of all deals and a meager 1.6% of all investment at that stage. This precipitous drop in both deal count and capital allocation highlights a fundamental shift in investor appetite and strategy. The market has moved from a diversified approach, where various stages and sizes of companies could find appropriate funding, to one that increasingly favors concentration and scale.

Only Room for Big Fish: The Deepening Capital Concentration

So, what precisely triggered this seismic shift? The underlying dynamics bear a striking resemblance to trends observed earlier in the funding lifecycle, particularly at the seed stage. Once a domain primarily characterized by rounds of a few million dollars, seed funding now routinely features deals exceeding $100 million. While smaller seed rounds still occur, they are no longer where the asset class is concentrating its capital. The same phenomenon is now playing out, with amplified intensity, at the late stage.

One overarching explanation for this widespread capital concentration across stages is an increasing investor consensus regarding who they perceive as the "likely big winners." In an environment characterized by intense competition and the potential for winner-take-all markets (especially in areas like AI), investors are less inclined to spread their bets thinly across numerous ventures. Instead, they are consolidating their capital behind a select few perceived "standouts" – companies that exhibit exponential growth potential, strong market leadership, or disruptive technological innovation. This approach, while seemingly logical in a world where top public companies command multi-trillion-dollar valuations, implicitly acknowledges that only a tiny fraction of venture-backed companies will ever reach the public markets, let alone achieve such stratospheric valuations. The venture capital "power law" is asserting itself more forcefully than ever, pushing investors to chase the few outliers with the potential for outsized returns, rather than funding a broader portfolio of merely "good" companies. The fear of missing out (FOMO) on the next AI giant further fuels this concentration, creating a self-reinforcing cycle where capital flows predominantly to those already deemed front-runners.

Adding to this dynamic is a constrained and challenging environment for traditional acquirers, which historically provided crucial exit paths for many late-stage startups. In the past, selling to a tech giant was a viable and often lucrative option for a non-unicorn company. These acquisitions allowed startups to achieve liquidity for their founders and investors, even if they didn’t become independent public entities. However, today, concerns surrounding antitrust scrutiny, increased regulatory oversight, and a general shift in strategic priorities have led the largest technology companies to significantly pull back on smaller M&A deals. The "Big Five" tech companies, in particular, have shown scant appetite for small-scale acquisitions, preferring either to develop capabilities internally or to pursue larger, more strategic targets. This effectively closes off a critical exit avenue for many promising, but not gargantuan, late-stage companies.

Private equity (PE) firms, another significant source of acquisitions for maturing startups, have also become less active lately. The primary reason is the sustained period of higher borrowing costs. PE firms often rely heavily on debt financing to fund their acquisitions, leveraging companies to enhance returns. Venture-backed startups, however, typically operate with negative cash flow or very limited free cash flow, making them poor candidates for servicing significant debt loads. This disconnect makes them less attractive targets for PE, which is increasingly focused on more mature, cash-generating businesses. The era of "growth equity" firms aggressively buying into rapidly scaling, but unprofitable, tech companies has receded, replaced by a more cautious, yield-focused approach.

The bottom line is that there are simply not as many clear and accessible paths to the "good-but-not-phenomenal" type of exit that a later-stage startup could realistically envision a few years ago. While startups are indeed still acquiring other startups, these transactions are often smaller, strategic "acquihire" deals or product integrations rather than substantial liquidity events designed to return significant capital to investors. These smaller, startup-on-startup deals, while beneficial for the acquired company’s team and technology, rarely provide the kind of financial return that justifies a large late-stage venture investment. This broader liquidity crunch at the exit stage naturally makes investors more selective at the funding stage, pushing them towards companies with a clearer, albeit higher, potential for a massive IPO or a truly transformative acquisition.

The Paradox of Need vs. Opportunity

Paradoxically, the preeminent use case for a smaller late-stage round today may have less to do with a clear path to a massive exit and more with the company’s internal needs. Some companies genuinely may not require a multi-hundred-million-dollar war chest to achieve their next critical milestone. They might be capital-efficient, operating in niche markets, or simply needing a moderate infusion to push through a product launch, expand into a new region, or weather a temporary market downturn. Yet, without any fresh capital, even a modest amount, these companies are unlikely to get to their next milestone at all. They find themselves in a challenging bind: they don’t fit the "mega-round" profile, but the market has largely abandoned the "modest-round" option.

This scenario sounds uncannily like real life, where practical needs often dictate financial requirements. However, the startup funding world, particularly at the late stage, is increasingly resembling this less and less. It’s evolving into a binary environment where companies are either seen as having the potential for astronomical returns, attracting vast sums, or they are deemed too small, too niche, or too slow-growing to warrant significant venture interest.

The implications of this trend are far-reaching. For founders, it means an even greater pressure to demonstrate hyper-growth and market dominance from an earlier stage, often forcing them into a "grow at all costs" mentality that may not be sustainable or even optimal for their specific business. For innovation, it risks stifling diverse ideas and business models that may not fit the mega-round mold but could still create significant value and impact. The concentration of capital in a few hands could lead to a less resilient and less diverse ecosystem in the long run. The fading of small late-stage rounds is not just a statistical anomaly; it is a fundamental restructuring of how venture capital operates, with profound consequences for the future of startups and the broader economy.

Related Crunchbase query:

• US Late-Stage Funding Rounds <$30M (2016-2026)
• Top US Late-Stage Funding Rounds (2023-2026)
• M&A by Big Tech Companies (2020-2025)
• Private Equity Investment in Venture-Backed Companies (2020-2025)

Related reading:

• The Great Consolidation: How VC is Reshaping Itself Around Mega-Deals
• Why Big Tech Acquisitions Have Slowed Down
• The New Reality of Startup Exits: Fewer IPOs, More Acqui-hires
• Is the Seed Stage the New Series A?
• The Impact of High Interest Rates on Private Equity
• The Generative AI Gold Rush: Who’s Getting the Billions?

Illustration: Dom Guzman

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.